B

Tier

Gonadorelin (GnRH)

Gonadorelin (GnRH)

Gonadorelin (GnRH)

Synthetic GnRH decapeptide for reproductive-axis stimulation.

Peptide, 10 amino acids

WADA Status:

Prohibited in males (S2.2.1)

Human Trial Scoreboard

Completed human RCTs

0
0
0

Count not verified

Largest Human Study

0
0
0

Size not verified

Longest exposure

0
0
0

Duration not verified

Most Recent Trial

0
0
0

Year not verified

Description

Gonadorelin is synthetic gonadotropin-releasing hormone, a ten amino acid signal produced by the hypothalamus that instructs the pituitary to release the hormones which in turn drive testosterone and oestrogen production. It was historically an approved medicine in the US under names including and Lutrepulse, used diagnostically to assess pituitary function and therapeutically in certain fertility contexts, and some of those products were later discontinued commercially. It remains widely used in veterinary medicine and in endocrinology. In fitness communities it is marketed as a testosterone restart, which is a use it was not approved for and which conflates it with hCG, a different hormone acting at a different point in the pathway.

What Are The Claims

Claims made for this compound: Maintains testicular function; Stimulates LH and FSH

Evidence

The historical approval was diagnostic. Its current popularity in hormone-therapy contexts is off-label and rests on the older approval as implied reassurance.

Evidence Strength

Moderate (legacy approved diagnostic; off-label now)

Caveats

Prescription-only; FDA-approved formulations require a valid prescription; off-label use for hormone therapy is not FDA-sanctioned; not available OTC.

Safety
Alternative Measures
Legal Status

US

Historically approved; some products discontinued, compounding category only

UK

Approved for diagnostic use in some markets

EU

Approved for diagnostic use in some markets

AU

Varies

WADA

Prohibited in males (S2.2.1)

Was FDA-approved as a diagnostic agent, then withdrawn from the US market. Current access is through compounding or grey-market channels.

Citations

No completed peer-reviewed human clinical trial exists for this compound. Where a citation is absent below, that absence is the finding.

The content on this site is provided for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. Aambrosia sells subscription access to editorial and research content only, no supplement, compound, or other physical product discussed on this site is sold, shipped, or dispensed by Aambrosia. Always consult a qualified healthcare provider before making changes to your diet, supplement routine, or health practices. Aambrosia does not guarantee specific results, and individual outcomes may vary

Culver City California
Support: bio.aambrosia@gmail.com